| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $259.2M | -10.3% |
| Cost of Revenue | $150.9M | +1.4% |
| R&D Expense | $19.2M | +11.2% |
| SG&A Expense | $161.8M | +6.9% |
| Operating Income | -$235.6M | -644.5% |
| Pre-tax Income | -$261.5M | -142.3% |
| Income Tax | -$1.9M | -100.2% |
| Net Income | -$144.8M | -21.7% |
| EPS (Basic) | -$1.05 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $322.4M | -43.9% |
| Accounts Receivable | $38.5M | -29.5% |
| Inventory | $50.1M | -2.6% |
| Current Assets | $429.1M | -38.7% |
| Total Assets | $1.01B | -32.2% |
| Current Liabilities | $57.0M | -34.9% |
| Long-term Debt | $295.9M | -43.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $7.5M | -94.1% |
| Capital Expenditures | $29.7M | -54.8% |
| Investing Cash Flow | -$24.3M | +80.1% |
| Financing Cash Flow | -$235.7M | -285.8% |
| Free Cash Flow | -$22.2M | -136.6% |
| -16.7% |
| EPS (Diluted) | -$1.05 | -16.7% |
| Total Liabilities |
| $431.0M |
| -38.2% |
| Stockholders' Equity | $325.3M | -21.9% |